Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Topical neomycin |
Is a |
False |
Framycetin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Framycetin adverse reaction |
Causative agent (attribute) |
False |
Framycetin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neomycin adverse reaction |
Causative agent (attribute) |
False |
Framycetin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to framycetin (finding) |
Causative agent (attribute) |
False |
Framycetin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely framycetin sulfate 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Framycetin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Framycetin sulfate 5 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Framycetin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing framycetin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Framycetin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Framycetin sulfate [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Framycetin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Framycetin sulfate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Framycetin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Framycetin sulfate [ear] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Framycetin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Framycetin sulfate [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Framycetin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Framycetin sulfate |
Is a |
False |
Framycetin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to framycetin (finding) |
Causative agent (attribute) |
True |
Framycetin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Framycetin sulfate |
Is modification of (attribute) |
True |
Framycetin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing framycetin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Framycetin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only framycetin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Framycetin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Framycetin only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Framycetin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing framycetin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Framycetin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only framycetin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Framycetin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |